VHL and renal cell carcinoma: Since the study also included patients with VHL-associated RCC and other VHL-associated tumors, responses were also observed in non-RCC lesions, including pancreatic neuroendocrine tumors (ORR 91%) and central nervous system hemangioblastomas (ORR 30%).